EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE.

1 total filings · 0 classes · Active since Nov 2025

EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 35 (Advertising & Business) with 1 filings. The WikiTrademarks Expansion Score is 4/100, low — the brand is focused on defending its existing categories rather than expanding.

USPTO data refreshed July 9, 2026

Own this brand? Claim the profile to add your logo, story, and website.

Sign in to claim

How is EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. filing trademarks, and where is the portfolio expanding?

Filing Velocity (24 Months)

Aug 2024 Jul 2026

Filing Activity by NICE Class

Nice Class Distribution

Activity Timeline

No activity recorded yet.

Recent Filings

Serial No. Mark Filing Date Status Classes Owner
99495433 EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. Nov 13, 2025 Registered 035 Advertising & Business Acey RX LLC
See how ChatGPT talks about EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. Beta

Weekly visibility reports showing how ChatGPT mentions EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE., where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.

Join waitlist →

FAQ: EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. trademark portfolio

What trademarks does EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. hold?

EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 35 (Advertising & Business). The most recent filings are registered to Acey RX LLC.

How many trademarks does EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. have at the USPTO?

WikiTrademarks tracks 1 USPTO trademark filings attributed to EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE.. The brand has been actively filing since November 2025. The count updates daily as new filings are indexed from the USPTO bulk data feed.

In which NICE classes does EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. file most often?

EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE.'s most active class is NICE Class 35 (Advertising & Business), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.

Who owns the EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. trademark?

The most recent filings under the EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. mark are registered to Acey RX LLC. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.

Is EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. expanding into new categories?

The current WikiTrademarks Expansion Score for EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. is 4 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.

How can I track new EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. trademark filings?

Click the Watch Brand button at the top of this page to add EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.

More on this portfolio: Compare EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. to another owner · Browse all NICE classes · Most valuable brands

Community notes

0 notes
Sign in to add a note

Share what you know about EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE. and help the next person researching it.

No notes yet. Be the first to add what you know about EMPOWERING PHARMACIES TO THRIVE. YOUR SUCCESS, OUR PLEDGE..